Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
17%
OVERLAP
BY WEIGHT
37
# OF OVERLAPPING
HOLDINGS
CANC
54
HOLDINGS
69%
ALSO IN IBB
IBB
261
HOLDINGS
18%
ALSO IN CANC
SECTOR DRIFT (CANC minus IBB)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CANC |
Weight in IBB |
Overlap | |
|---|---|---|---|---|
 |
AMGEN INC | 2.2% | 7.8% | 2.2% |
|
BEIGENE LTD. SPONSORED ADR | 2.1% | 2.0% | 2.0% |
|
GILEAD SCIENCES INC | 1.5% | 8.0% | 1.5% |
 |
GENMAB A/S SPONSORED ADR | 3.9% | 1.4% | 1.4% |
|
REVOLUTION MEDICINES, INC. | 6.3% | 1.2% | 1.2% |
CANC Overweight Relative to IBB
|
ELI LILLY & CO | 5.2% |
|
REVOLUTION MEDICINES, INC. | 5.1% |
 |
ASTRAZENECA PLC | 4.3% |
 |
NOVARTIS AG | 4.2% |
|
ROCHE HOLDINGS LTD-SPONS ADR | 4.0% |
|
MERCK & CO. INC. | 3.6% |
|
BRISTOL-MYERS SQUIBB CO | 3.4% |
|
BRIDGEBIO PHARMA, INC. | 3.2% |
|
COGENT BIOSCIENCES INC | 3.1% |
|
JOHNSON & JOHNSON | 3.0% |
CANC Underweight Relative to IBB
|
VERTEX PHARMACEUTICALS INC | -8.7% |
|
GILEAD SCIENCES INC | -6.6% |
|
REGENERON PHARMACEUTICALS | -5.8% |
|
AMGEN INC | -5.6% |
|
ALNYLAM PHARMACEUTICALS INC | -4.5% |
|
INSMED INC | -3.2% |
|
NATERA INC | -2.7% |
|
BIOGEN IDEC INC | -2.3% |
 |
ARGENX SE ADR | -2.0% |
|
UNITED THERAPEUTICS CORP | -1.8% |